(Q40214312)

18 September 2017

title

Development of a Rift Valley fever virus viremia challenge model in sheep and goats (English)

1 reference

Rift Valley fever phlebovirus

18 September 2017

main subject

0 references

Rift Valley fever

1 reference

based on heuristic

inferred from title

Rift Valley fever virus

object named as

Rift Valley fever virus

1 reference

Hana M Weingartl

1

1 reference

18 September 2017

Myrna Miller

series ordinal

2

1 reference

18 September 2017

Charles Nfon

series ordinal

3

1 reference

18 September 2017

William C Wilson

series ordinal

4

1 reference

18 September 2017

language of work or name

English

0 references

publication date

12 March 2014

1 reference

18 September 2017

1 reference

18 September 2017

volume

32

1 reference

18 September 2017

issue

20

1 reference

18 September 2017

page(s)

2337-2344

1 reference

Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

7 January 2021

Rift Valley fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Rift valley fever: recent insights into pathogenesis and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Efficacy of three candidate Rift Valley fever vaccines in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Development and evaluation of one-step rRT-PCR and immunohistochemical methods for detection of Rift Valley fever virus in biosafety level 2 diagnostic laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Experimental infection of young adult European breed sheep with Rift Valley fever virus field isolates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Animal models of Rift Valley fever virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Pathological studies on postvaccinal reactions of Rift Valley fever in goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Innate immune response to Rift Valley fever virus in goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Characterization of Attenuated Strains of Rift Valley Fever Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Host alternation is necessary to maintain the genome stability of rift valley fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

DC-SIGN as a receptor for phleboviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

DC-SIGN and L-SIGN Can Act as Attachment Receptors for Alphaviruses and Distinguish between Mosquito Cell- and Mammalian Cell-Derived Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Differential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived Alphaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

Development of a novel nonhuman primate model for Rift Valley fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.02.066

10.1016/J.VACCINE.2014.02.066

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference